A once-monthly treatment for opioid use disorder

from Listen to The Lancet · host The Lancet

Mark Greenwald discusses buprenorphine extended release—a once-monthly injected formulation for the treatment of opioid use disorder recently approved by the US FDA.

Episode metadata supplied by the publisher feed · Published Feb 18, 2019

Embed this episode

Attribution link and audio player

NOW PLAYING

A once-monthly treatment for opioid use disorder

0:00 12:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 12 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on February 18, 2019.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!